StockData
Stemtech Corp logo

Stemtech Corp (STEK) stock

STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $296.22KP/E –Yield –

Stemtech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Stemtech's revenue for the twelve months ending Sep 30, 2026 was $1.83M, down 50.9% year over year. For fiscal 2025 it was $2.88M, down 43.1% from the year before. The highest annual figure on record is $5.05M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.88M-43.1%
FY2024Dec 31, 2024$5.05M+2.7%
FY2023Dec 31, 2023$4.92M+7.9%
FY2022Dec 31, 2022$4.56M+5.5%
FY2021Dec 31, 2021$4.32M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Sep 30, 2026$282.48K-66.9%
Q2 FY2026CQ2 2026Jun 30, 2026$629.31K-9.8%
Q1 FY2026CQ1 2026Mar 31, 2026$462.96K-46.7%
Q4 FY2025CQ4 2025Dec 31, 2025$458.11K-65.1%
Q3 FY2025CQ3 2025Sep 30, 2025$852.30K-17.4%
Q2 FY2025CQ2 2025Jun 30, 2025$697.93K-47.4%
Q1 FY2025CQ1 2025Mar 31, 2025$868.05K-37.2%
Q4 FY2024CQ4 2024Dec 31, 2024$1.31M-3.5%
Q3 FY2024CQ3 2024Sep 30, 2024$1.03M-20.5%
Q2 FY2024CQ2 2024Jun 30, 2024$1.33M+17.5%
Q1 FY2024CQ1 2024Mar 31, 2024$1.38M+22.0%
Q4 FY2023CQ4 2023Dec 31, 2023$1.36M+26.1%
Q3 FY2023CQ3 2023Sep 30, 2023$1.30M+24.0%
Q2 FY2023CQ2 2023Jun 30, 2023$1.13M-11.6%
Q1 FY2023CQ1 2023Mar 31, 2023$1.13M-2.0%
Q4 FY2022CQ4 2022Dec 31, 2022$1.08M+0.4%
Q3 FY2022CQ3 2022Sep 30, 2022$1.05M–
Q2 FY2022CQ2 2022Jun 30, 2022$1.28M–
Q1 FY2022CQ1 2022Mar 31, 2022$1.16M–
Q1 FY2021CQ1 2021Mar 31, 2021$1.08M–

More Stemtech figures

See a number that looks wrong?